8-K: Current report filing
Published on May 19, 1999
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) May 17, 1999
COMMONWEALTH BIOTECHNOLOGIES, INC.
(Exact Name of Registrant as Specified in Charter)
601 Biotech Drive, Richmond, Virginia 23235
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (804) 648-3820
N/A
(Former Name or Former Address, if Changed Since Last Report)
ITEM 5. OTHER EVENTS.
On May 14, 1999, Commonwealth Biotechnologies, Inc., a Virginia
corporation (the "Registrant"), announced the appointment of Raymond H. Cypress,
D.V.M., Ph.D., the President and Chief Executive Officer of the American Type
Culture Collection, to its Board of Directors.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(a) FINANCIAL STATEMENTS OF BUSINESSES ACQUIRED.
Not applicable.
(b) PRO FORMA FINANCIAL INFORMATION.
Not applicable.
(c) EXHIBITS.
99.1 Press Release, dated May 14, 1999, announcing the
appointment of Raymond H. Cypress to the Registrant's
Board of Directors.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
COMMONWEALTH BIOTECHNOLOGIES, INC.
By: /s/ James H. Brennan
----------------------------
James H. Brennan
Controller
May 17, 1999
EXHIBIT INDEX
Number Description of Exhibit
- ------ ----------------------
99.1 Press Release, dated May 14, 1999, announcing the appointment
of Raymond H. Cypress to the Registrant's Board of Directors.